Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

ProPhase Labs (PRPH) Gross Margin: 2010-2025

Historic Gross Margin for ProPhase Labs (PRPH) over the last 16 years, with Sep 2025 value amounting to -13.93%.

  • ProPhase Labs' Gross Margin fell 2911.00% to -13.93% in Q3 2025 from the same period last year, while for Sep 2025 it was 19.41%, marking a year-over-year decrease of 59455.00%. This contributed to the annual value of -2.21% for FY2024, which is 4665.00% down from last year.
  • Latest data reveals that ProPhase Labs reported Gross Margin of -13.93% as of Q3 2025, which was down 123.67% from 58.86% recorded in Q2 2025.
  • ProPhase Labs' Gross Margin's 5-year high stood at 64.35% during Q2 2022, with a 5-year trough of -13.93% in Q3 2025.
  • Moreover, its 3-year median value for Gross Margin was 27.82% (2023), whereas its average is 24.44%.
  • In the last 5 years, ProPhase Labs' Gross Margin plummeted by 7,338bps in 2024 and then surged by 6,917bps in 2025.
  • ProPhase Labs' Gross Margin (Quarterly) stood at 54.52% in 2021, then slumped by 281bps to 51.70% in 2022, then soared by 1,183bps to 63.53% in 2023, then tumbled by 7,338bps to -9.84% in 2024, then tumbled by 2,911bps to -13.93% in 2025.
  • Its Gross Margin was -13.93% in Q3 2025, compared to 58.86% in Q2 2025 and 36.76% in Q1 2025.